glaxosmithkline

September 22, 2021
Pharma giant GlaxoSmithKline (GSK) is targeting a 20MW solar project to help power its manufacturing facility in Irvine, Scotland.

Email Newsletter

Upcoming Events

Solar Finance & Investment Europe 2025

4 February 2025
London, UK
17 February 2025
London, UK
11 March 2025
Frankfurt, Germany
29 April 2025
Dallas, Texas
7 May 2025
Munich, Germany

You are now subscribed!

Thank you for subscribing to the email newsletter. You can opt-out at any time.